503 related articles for article (PubMed ID: 24462659)
1. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
Tsuji JS; Alexander DD; Perez V; Mink PJ
Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
[TBL] [Abstract][Full Text] [Related]
2. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis.
Mink PJ; Alexander DD; Barraj LM; Kelsh MA; Tsuji JS
Regul Toxicol Pharmacol; 2008 Dec; 52(3):299-310. PubMed ID: 18783726
[TBL] [Abstract][Full Text] [Related]
3. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
Lamm SH; Robbins SA; Zhou C; Lu J; Chen R; Feinleib M
Regul Toxicol Pharmacol; 2013 Feb; 65(1):147-56. PubMed ID: 23137931
[TBL] [Abstract][Full Text] [Related]
4. Bayesian benchmark dose analysis for inorganic arsenic in drinking water associated with bladder and lung cancer using epidemiological data.
Shao K; Zhou Z; Xun P; Cohen SM
Toxicology; 2021 May; 455():152752. PubMed ID: 33741492
[TBL] [Abstract][Full Text] [Related]
5. Risk assessment of arsenic-induced internal cancer at long-term low dose exposure.
Liao CM; Shen HH; Chen CL; Hsu LI; Lin TL; Chen SC; Chen CJ
J Hazard Mater; 2009 Jun; 165(1-3):652-63. PubMed ID: 19062162
[TBL] [Abstract][Full Text] [Related]
6. Environmental risk assessment of arsenic and fluoride in the Chaco Province, Argentina: research advances.
Buchhamer EE; Blanes PS; Osicka RM; Giménez MC
J Toxicol Environ Health A; 2012; 75(22-23):1437-50. PubMed ID: 23095162
[TBL] [Abstract][Full Text] [Related]
7. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.
Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D
Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537
[TBL] [Abstract][Full Text] [Related]
8. Use of mode of action data to inform a dose-response assessment for bladder cancer following exposure to inorganic arsenic.
Gentry PR; Yager JW; Clewell RA; Clewell HJ
Toxicol In Vitro; 2014 Oct; 28(7):1196-205. PubMed ID: 24937311
[TBL] [Abstract][Full Text] [Related]
9. Discontinuity in the cancer slope factor as it passes from high to low exposure levels--arsenic in the BFD-endemic area.
Lamm SH; Robbins S; Chen R; Lu J; Goodrich B; Feinleib M
Toxicology; 2014 Dec; 326():25-35. PubMed ID: 25241138
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data.
Lynch HN; Zu K; Kennedy EM; Lam T; Liu X; Pizzurro DM; Loftus CT; Rhomberg LR
Environ Int; 2017 Sep; 106():178-206. PubMed ID: 28625818
[TBL] [Abstract][Full Text] [Related]
11. Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence.
Saint-Jacques N; Parker L; Brown P; Dummer TJ
Environ Health; 2014 Jun; 13():44. PubMed ID: 24889821
[TBL] [Abstract][Full Text] [Related]
12. Arsenic exposure in US public and domestic drinking water supplies: a comparative risk assessment.
Kumar A; Adak P; Gurian PL; Lockwood JR
J Expo Sci Environ Epidemiol; 2010 May; 20(3):245-54. PubMed ID: 19401722
[TBL] [Abstract][Full Text] [Related]
13. Ingested arsenic, characteristics of well water consumption and risk of different histological types of lung cancer in northeastern Taiwan.
Chen CL; Chiou HY; Hsu LI; Hsueh YM; Wu MM; Chen CJ
Environ Res; 2010 Jul; 110(5):455-62. PubMed ID: 19735913
[TBL] [Abstract][Full Text] [Related]
14. Bladder cancer and arsenic through drinking water: a systematic review of epidemiologic evidence.
Christoforidou EP; Riza E; Kales SN; Hadjistavrou K; Stoltidi M; Kastania AN; Linos A
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2013; 48(14):1764-75. PubMed ID: 24007431
[TBL] [Abstract][Full Text] [Related]
15. Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from northeastern Taiwan.
Chen CL; Chiou HY; Hsu LI; Hsueh YM; Wu MM; Wang YH; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):101-10. PubMed ID: 20056628
[TBL] [Abstract][Full Text] [Related]
16. Arsenic cancer risk posed to human health from tilapia consumption in Taiwan.
Liao CM; Shen HH; Lin TL; Chen SC; Chen CL; Hsu LI; Chen CJ
Ecotoxicol Environ Saf; 2008 May; 70(1):27-37. PubMed ID: 18068227
[TBL] [Abstract][Full Text] [Related]
17. Arsenic: bioaccessibility from seaweed and rice, dietary exposure calculations and risk assessment.
Brandon EF; Janssen PJ; de Wit-Bos L
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2014; 31(12):1993-2003. PubMed ID: 25393691
[TBL] [Abstract][Full Text] [Related]
18. Estimating the risk of bladder and kidney cancer from exposure to low-levels of arsenic in drinking water, Nova Scotia, Canada.
Saint-Jacques N; Brown P; Nauta L; Boxall J; Parker L; Dummer TJB
Environ Int; 2018 Jan; 110():95-104. PubMed ID: 29089168
[TBL] [Abstract][Full Text] [Related]
19. Assessment of cancer risk and environmental levels of arsenic in New Hampshire.
Karagas MR; Stukel TA; Tosteson TD
Int J Hyg Environ Health; 2002 Mar; 205(1-2):85-94. PubMed ID: 12018020
[TBL] [Abstract][Full Text] [Related]
20. P53 alterations in bladder tumors from arsenic and tobacco exposed patients.
Moore LE; Smith AH; Eng C; DeVries S; Kalman D; Bhargava V; Chew K; Ferreccio C; Rey OA; Hopenhayn C; Biggs ML; Bates MN; Waldman FM
Carcinogenesis; 2003 Nov; 24(11):1785-91. PubMed ID: 12919957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
